Within a latest study, we documented the identification and the characterization of a completely new atypical opioid receptor with unique adverse regulatory Homes in direction of opioid peptides.1 Our effects confirmed that ACKR3/CXCR7, hitherto generally known as an atypical scavenger receptor for chemokines CXCL12 and CXCL11, can also be https://zbigniews809ngz3.qodsblog.com/profile